Dr. David E. Rivadeneira, MD

Dr. Rivadeneira practices at Digestive Health Center of Huntington in Huntington, New York.

Dr. Rivadeneira's NPI, 1457370785, was assigned on July 18, 2006. Dr. Rivadeneira graduated from Howard University College Of Medicine in 1995. Dr. Rivadeneira's New York license number on file is 212811.

Dr. Rivadeneira's primary practice is Digestive Health Center of Huntington, at 195 East Main Street, Huntington, NY 11743. The practice phone is (631) 385-8677.

Dr. Rivadeneira's primary practice is Digestive Health Center of Huntington in Huntington, New York. Dr. Rivadeneira is also affiliated with Huntington Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Rivadeneira to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rivadeneira practices, 6 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Rivadeneira's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Rivadeneira is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dr. Rivadeneira has a license on file in New York.

Dmand AI lists colonoscopy, colon removal, gastrointestinal obstruction and hemorrhoids among the conditions Dr. Rivadeneira treats.

CMS data shows 1,213 Medicare services from Dr. Rivadeneira across 22 procedure codes in 2024, for 434 Medicare patients. Medicare paid $266,841 for them.

CMS counts 434 Medicare patients who saw Dr. Rivadeneira in 2024. The largest group is 65 to 74, with 203 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rivadeneira's median patient age at 62, with 49% women.

In 2024, Dr. Rivadeneira wrote 239 Medicare Part D claims for 121 patients. 92% of them were for generic drugs. CMS names the drug for 165 of them, across 5 drugs with 11 or more claims each, at $3,993 in total drug cost. In 2023, CMS named 56 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Rivadeneira for performance year 2024, reported through an alternative payment model (APM). Dr. Rivadeneira accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rivadeneira as offering telehealth. CMS counts 155 procedures of colonoscopy by Dr. Rivadeneira, more than 89% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 36 papers to Dr. Rivadeneira, published from 2000 to 2019. 2012 was the busiest year, with 4. The most frequent topics are Colectomy, Colonic Neoplasms and Tomography, X-Ray Computed. Dr. Rivadeneira has published most often in Dis Colon Rectum. Dr. Rivadeneira's most frequent co-authors are Scott Russell Steele, MD, Justin A. Maykel, MD and Marlin W. Causey, MD.

CMS Open Payments shows 480 general payments to Dr. Rivadeneira from 55 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Integra LifeSciences Corporation paid the most, $117,743.

Dmand AI lists 39 awards for Dr. Rivadeneira, most recently Castle Conolly Top Doctors in 2022.

Dr. Rivadeneira graduated from Howard University College Of Medicine in 1995. Dr. Rivadeneira is a member of AOA, ACS and ASCRS.

Dr. Rivadeneira is in network with 18 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.